Back to Search
KATELYN WARD, MD
MD
Surgery Physician
NPI: 1316514458Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats.
PMID 17374674·J Nutr·2007
7-preclinical
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
PMID 16019946·Xenobiotica·2005
4-observational
Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion.
PMID 15268981·Xenobiotica·2004
4-observational
Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations.
PMID 15268980·Xenobiotica·2004
4-observational
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.
PMID 15155552·Drug Metab Dispos·2004
4-observational
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
PMID 15155551·Drug Metab Dispos·2004
4-observational
Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, dog, and monkey.
PMID 15056727·J Pharmacol Exp Ther·2004
4-observational
Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
PMID 14744938·Drug Metab Dispos·2004
4-observational
Enhancement of in vitro and in vivo microdialysis recovery of SB-265123 using Intralipid and Encapsin as perfusates.
PMID 12516075·Biopharm Drug Dispos·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 3601 W 13 MILE RD OFC
ROYAL OAK, MI 48073 - Phone
- (248) 898-2673
Quick Facts
- NPI
- 1316514458
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile